Biosynex SA
PAR:ALBIO

Watchlist Manager
Biosynex SA Logo
Biosynex SA
PAR:ALBIO
Watchlist
Price: 2.9 EUR -3.17% Market Closed
Market Cap: 31.2m EUR
Have any thoughts about
Biosynex SA?
Write Note

Biosynex SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biosynex SA
Revenue Peer Comparison

Comparables:
EDAP
BIM
ALCAR
ALVMG
AMPLI

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Biosynex SA
PAR:ALBIO
Revenue
€93m
CAGR 3-Years
-15%
CAGR 5-Years
24%
CAGR 10-Years
48%
Edap Tms SA
NASDAQ:EDAP
Revenue
€60.4m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
10%
Biomerieux SA
PAR:BIM
Revenue
€3.8B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
9%
Carmat SA
PAR:ALCAR
Revenue
€5.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Visiomed Group SA
PAR:ALVMG
Revenue
€13.7m
CAGR 3-Years
-10%
CAGR 5-Years
9%
CAGR 10-Years
2%
Amplitude Surgical SA
PAR:AMPLI
Revenue
€104m
CAGR 3-Years
7%
CAGR 5-Years
0%
CAGR 10-Years
N/A

See Also

What is Biosynex SA's Revenue?
Revenue
93m EUR

Based on the financial report for Dec 31, 2023, Biosynex SA's Revenue amounts to 93m EUR.

What is Biosynex SA's Revenue growth rate?
Revenue CAGR 10Y
48%

Over the last year, the Revenue growth was -53%. The average annual Revenue growth rates for Biosynex SA have been -15% over the past three years , 24% over the past five years , and 48% over the past ten years .

Back to Top